Fabrice CARRAT

Responsibilities

Director of IPLESP

Selected publications

 - Carrat F, Fontaine H, Dorival C, Simony M, Diallo A, Hezode C, et al. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet. 2019;393(10179):1453-64.

- Audureau E, Carrat F, Layese R, Cagnot C, Asselah T, Guyader D, et al. Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status. J Hepatol. 2020;73(6):1434-45.

- Carrat F, Nahon P, Fontaine H, Pol S, Hejblum G. Comparing interferon-free with interferon-based regimens in HCV patients: Rogers phenomenon and Simpson's paradox. J Viral Hepat. 2020;27(3):329-32.

- Carrat F, de Lamballerie X, Rahib D, Blanche H, Lapidus N, Artaud F, et al. Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study. Int J Epidemiol. 2021;50(5):1458-72.

- Carrat F, Figoni J, Henny J, Desenclos JC, Kab S, de Lamballerie X, et al. Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort. Eur J Epidemiol. 2021;36(2):219-22.

International collaborations

Clinical teams in EU, Africa, Asia and North America working on epidemiology of chronic viral diseases

Industrial collaborations

Pharmaceutical companies (Gilead, Abbvie, MSD, Janssen, BMS, Roche)